SCHEMBL144408

SCHEMBL144408

C=CN=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8517985 0.69
SCHEMBL10457098 0.67
SCHEMBL10177513 0.67
SCHEMBL11820116 0.64
SCHEMBL1149417 0.62
SCHEMBL14330322 0.59
SCHEMBL1800841 0.59
SCHEMBL14580 0.59
SCHEMBL16623329 0.59
SCHEMBL312476 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239807-B2 Fused cyclooctyne compounds and their use in metal-free click reactions SYNAFFIX B.V. (NL) 2019-03-26 US claimed
US-7115640-B2 Heterocyclic modulators of nuclear receptors X-CEPTOR THERAPEUTICS, INC. (US) 2006-10-03 US claimed
EP-1537177-B1 WATER ABSORBING AGENT AND METHOD FOR THE PRODUCTION THEREOF BASF AG (DE) 2006-08-16 EP claimed
US-20050245684-A1 Water absorbing agent and method for the production thereof BASF AKTIENGESELLSCHAFT, A GERMAN CORPORATION (DE) 2005-11-03 US claimed
EP-1465882-A4 HETROCYCLIC MODULATORS OF NUCLEAR RECEPTORS X CEPTOR THERAPEUTICS INC (US) 2005-04-06 EP claimed
EP-1031585-B1 Method of preparation of aqueous dispersions from copolymers of hydrophilic and hydrophobic monomers BASF AG (DE) 2004-12-01 EP claimed
EP-1465882-A2 HETROCYCLIC MODULATORS OF NUCLEAR RECEPTORS X-Ceptor Therapeutics, Inc. (US) 2004-10-13 EP claimed
US-20040180942-A1 Heterocyclic modulators of nuclear receptors X-CEPTOR THERAPEUTICS, INC. 2004-09-16 US claimed
US-6696473-B2 THIAZOLIDINONE DERIVATIVES; MODULATING CHOLESTEROL METABOLISM X-CEPTOR THERAPEUTICS, INC. 2004-02-24 US claimed
WO-2003060078-A9 HETEROCYCLIC MODULATORS OF NUCLEAR RECEPTORS X CEPTOR THERAPEUTICS INC (US) 2004-02-19 WO claimed
WO-1999036375-A1 ASYMMETRIC CYCLOADDITION REACTIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-07-22 WO claimed
EP-0565683-A1 QUINOXALINE DERIVATES WITH AFFINITY FOR QUISQUALATE-RECEPTORS SCHERING AKTIENGESELLSCHAFT (DE) 1993-10-20 EP claimed
EP-0398258-B1 INDAN-1,3-DIONE DERIVATIVE AND HERBICIDAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT MITSUBISHI KASEI CORPORATION (JP) 1993-08-04 EP claimed
WO-1993008173-A1 QUINOXALINE DERIVATES WITH AFFINITY FOR QUISQUALATE-RECEPTORS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-29 WO claimed
US-5110342-A INDAN-1,3-DIONE DERIVATIVE AND HERBICIDAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT MITSUBISHI KASEI CORPORATION (JP) 1992-05-05 US claimed
US-5076830-A INDAN-1,3-DIONE DERIVATIVE AND HERBICIDAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT MITSUBISHI KASEI CORPORATION (JP) 1991-12-31 US claimed
EP-0282502-B1 IMIDAZOLE DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 1991-05-15 EP claimed
EP-0398258-A1 Indan-1,3-dione derivative and herbicidal composition containing the same as active ingredient MITSUBISHI KASEI CORPORATION (JP) 1990-11-22 EP claimed
EP-0282502-A1 IMIDAZOLE DERIVATIVES. SCHERING AG (DE) 1988-09-21 EP claimed
WO-1988001268-A1 IMIDAZOLE DERIVATIVES SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1988-02-25 WO claimed